MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$11,380K
Net Income
-$20,249K
Net Profit Margin
-177.93%
EPS
-$0.35
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
11,380
8,720
4,620*
-
Cost of sales
4,177
2,696
68*
488
Royalties
-
-
1,593*
-
Research and development
5,021
9,555
6,712
4,216
Selling, general and administrative
15,835
19,502
19,158*
19,314
Total costs and expenses
25,033
31,753
27,531*
24,018
Loss from operations
-13,653
-23,033
-22,911
-24,018
Interest income
1,355
1,354
1,547
1,672
Interest expense
696
830
884
901
Change in fair value of warrant liabilities
7,191
-5,386
-1,522
-2,760
Loss from sale of priority review voucher, net
-
-
-157
-
Other (loss) income, net
-6
50
51
129
(gain) income before income taxes
-20,191
-17,073
-20,832*
-20,358
Income tax expense
-
2
-372*
-15,197
Net (gain) income
-20,191
-17,075
-20,460
-5,161
Change in unrealized losses related to available-for-sale debt securities
-58
-159
128
55
Comprehensive (gain) income
-20,249
-17,234
-20,332
-5,106
Basic EPS
-0.35
-0.3
-0.368
-0.1
Diluted EPS
-0.35
-0.3
-0.217
-0.1
Basic Average Shares
57,048,385
56,620,920
55,265,850
54,242,507
Diluted Average Shares
57,048,385
56,620,920
93,881,356
54,242,507
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (gain) income
-$20,249K
(-118.60%↓ Y/Y)
Net (gain) income
-$20,191K
(-118.55%↓ Y/Y)
Change in unrealized
losses related to...
-$58K
(-363.64%↓ Y/Y)
(gain) income before
income taxes
-$20,191K
(-116.24%↓ Y/Y)
Interest income
$1,355K
(31.94%↑ Y/Y)
Loss from operations
-$13,653K
(40.10%↑ Y/Y)
Change in fair value of
warrant liabilities
$7,191K
(33.46%↑ Y/Y)
Total revenues
$11,380K
(2745.00%↑ Y/Y)
Interest expense
$696K
(-27.27%↓ Y/Y)
Other (loss) income,
net
-$6K
(-106.74%↓ Y/Y)
Total costs and
expenses
$25,033K
Selling, general and
administrative
$15,835K
(-7.66%↓ Y/Y)
Research and development
$5,021K
(-15.51%↓ Y/Y)
Cost of sales
$4,177K
Buy us a coffee
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)